Maude Tessier

Dr. Maude Tessier is a seasoned biopharma executive with 20 years of company building experience with a multi-disciplinary background in business development, corporate strategy, fundraising and investor relations, corporate communications, and IP & legal, portfolio and program management, in public and private biotechnology, pharmaceutical and academic organizations.

She currently provides business development, corporate strategy and operations advisory and interim management services for young biotech companies through Lobster Point Consulting LLC. She is the former COO of Hillstar Bio, a private preclinical-stage precision immunology biotech company, where she was responsible for BD & strategy, finance, legal, PR and operations. Previously, she served as CBO at Seismic Therapeutic, where she led financing, partnering and corporate strategy, including driving a $146M Series B financing. As CBO of Ikena Oncology, she built and managed business development, legal, and corporate strategy functions, in particular, leading a $1B+ strategic partnership with BMS and contributing to over $260M in capital raises. Maude’s career also includes leadership roles at Merck & Co., Boston Children’s Hospital, and Xanthus Pharmaceuticals. Maude holds a Ph.D. from the University of Toronto.